Actively Recruiting
Comparison of Intensive Versus Standard Care and Education for Dyslipidemia in Patients with Hypertension and Diabetes
Led by Saint Vincent's Hospital, Korea · Updated on 2025-07-01
348
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
Sponsors
S
Saint Vincent's Hospital, Korea
Lead Sponsor
H
Hanam City Center for Hypertension and Diabetes Registration
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to evaluate intensive dyslipidemia management and education for patients with hypertension and diabetes, conditions that often increase the risk of cardiovascular disease. The study seeks to improve blood lipid levels and assess how enhanced education affects patients' quality of life, health behaviors, and adherence to treatment. It also aims to contribute to the development of more effective management strategies through a structured and standardized approach. Participants are divided into two groups. The intensive care group receives two hours of group education on diabetes, high blood pressure, and lipid disorders delivered by a nurse and nutritionist, with follow-up education at three months and brief phone call education at two and four months. The standard care group receives one hour of group education on diabetes and high blood pressure only. Large group sessions led by doctors use a dialogue-oriented lecture format to engage participants. Throughout the six-month study, researchers will monitor changes in blood lipid levels, blood pressure, HbA1c, quality of life, and lifestyle habits using questionnaires and clinical measurements. Assessments occur at baseline and after six months. The study evaluates the cost-benefit impact of intensive education and aims to inform public health policies and national guidelines for managing dyslipidemia in chronic disease patients.
CONDITIONS
Brief Title
Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients registered in the Hanam City Hypertension and Diabetes Program
- Adults aged 30 to 80 years
- Individuals who have provided written informed consent to participate in the study
You will not qualify if you...
- Chronic kidney disease stage 4 or higher (eGFR <30 mL/min/1.73m²)
- Patients with liver cirrhosis or severe liver disease
- Patients with a history of acute coronary syndrome within the past 6 months
- Pregnant or breastfeeding women
- Individuals with psychiatric disorders that may affect study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants in the intensive care group receive structured education on diabetes, high blood pressure, and dyslipidemia through group sessions and follow-up non-face-to-face management calls to support lifestyle modifications and management.
3 in-person education visits and 2 brief phone calls
Duration - 6 months
Participants in the standard care group receive standard management education on diabetes and high blood pressure through one group education session.
1 in-person education visit
Trial Site Locations
Total: 1 location
1
Catholic University of Korea, ST. Vincent's Hospital.
Gyeonggi-do, Suwon-si, South Korea, 16247
Actively Recruiting
Research Team
S
Sung-Ho Her
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here